BibSonomy bookmarks for /user/avivagabriel/kinase

Mitogen-activated protein kinases partially regulate endothelin-1-induced contractions through a myosin light chain phosphorylation-independent pathway

avivagabriel — 2007-08-08T02:19:07+02:00

MAP Kinase p38 Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38-alpha Protein

avivagabriel — 2007-08-07T23:25:47+02:00

Mitogen-activated protein kinase p38 is a serin/threonine kinase originally isolated from lipopolysaccharide stimulated monocytes. There are 4 isoforms; p...Mitogen-activated protein kinase p38 is a serin/threonine kinase originally isolated from lipopolysaccharide stimulated monocytes. There are 4 isoforms; p38-a activation has been most widely studied for inflammation...

Delta Opioid activation of the Mitogen-activated protein kinase cascade does not require transphosphorylation of Receptor Tyrosine Kinases

avivagabriel — 2007-08-07T15:58:10+02:00

BMC Pharmacol. 2002. H Kenneth Kramer, et al.

International Immunopharmacology =.= Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-α-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-κB signaling pathways

avivagabriel — 2007-08-07T13:23:41+02:00

Inhibitors of Protein Kinase Signaling Pathways: Emerging Therapies for Cardiovascular Disease -- Force et al. 109 (10): 1196 -- Circulation

avivagabriel — 2007-08-07T13:15:59+02:00

Differential Signaling for MCP-1-Dependent Integrin Activation and Chemotaxis

avivagabriel — 2007-07-27T22:56:01+02:00

Dr. Noboru Ashida, Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaramachi, Shogoin Sakyo-ku, Kyoto 606-8507, Japan...Dr. Noboru Ashida, Department of Geriatric Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaramachi, Shogoin Sakyo-ku, Kyoto 606-8507, Japan. Voice +81-75-751-3465; fax: +81-75-751-3574; ash@kuhp.kyoto.u.ac.jp.

AltaVista Search: atherosclerosis p38 mitogen-activated kinase glaxo

avivagabriel — 2007-07-27T13:29:51+02:00

Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor

avivagabriel — 2007-07-27T01:39:38+02:00

Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia

avivagabriel — 2007-07-27T01:30:32+02:00

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY. Judith Branger, Bernt van den Blink, Sebastiaan Weijer, Abhya Gupta, Sander J.H. van Deventer, C. Erik Hack, ...HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY. Judith Branger, Bernt van den Blink, Sebastiaan Weijer, Abhya Gupta, Sander J.H. van Deventer, C. Erik Hack, Maikel P. Peppelenbosch, and Tom van der Poll

Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia

avivagabriel — 2007-07-27T00:43:26+02:00

The anti-inflammatory potential of an oral p38 MAPK inhibitor in humans in vivo suggests that p38 MAPK inhibitors may provide a new therapeutic option in t...The anti-inflammatory potential of an oral p38 MAPK inhibitor in humans in vivo suggests that p38 MAPK inhibitors may provide a new therapeutic option in the treatment of inflammatory diseases. Boehringer Ingelheim. 2002 Branger J, et al

Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury

avivagabriel — 2007-07-27T00:27:27+02:00

p38 MAPK inhibitors represent a novel therapeutic approach to the treatment of restenosis associated with coronary angioplasty.

ScienceDaily ~:> Beyond Lipids ~:> Understanding The Mechanics Of Atherosclerosis

avivagabriel — 2007-07-25T23:06:15+02:00